[
1. X. Huang, E. Dorhout Mees, P. Vos, S. Hamza and B. Braam, Everything we always wanted to know about furosemide but were afraid to ask, Am. J. Physiol.-Ren. Physiol. 310 (2016) 958–971; https://doi.org/10.1152/ajprenal.00476.2015
]Search in Google Scholar
[
2. S. Kumar and M. A. Kumar, Preformulation study of furosemide, Der Pharmacia Lettre 8 (2016) 214–222.
]Search in Google Scholar
[
3. G. Pacifici, Clinical pharmacology of furosemide in neonates: A review, Pharmaceuticals 6 (2013) 1094–1129; https://doi.org/0.3390/ph6091094
]Search in Google Scholar
[
4. S. W. Oh and S. Y. Han, Loop diuretics in clinical practice, Electrolytes Blood Press. 13 (2015) 17–21; https://doi.org/10.5049/EBP.2015.13.1.17
]Search in Google Scholar
[
5. S. Strauch, E. Jantratid, J. B. Dressman, H. E. Junginger, S. Kopp, K. K. Midha, V. P. Shah, S. Stavchansky and D. M. Barends. Biowaiver monographs for immediate release solid oral dosage forms: mefloquine hydrochloride, J. Pharm. Sci, 99 (2010) 2544–2556; https://doi.org/10.1002/jps.22249
]Search in Google Scholar
[
6. M. Vlachou and G. Papaïoannou, Preparation and characterization of the inclusion complex of furosemide with hydroxypropyl-b-cyclodextrin, J. Biomater. Appl. 17 (2003) 197–206; https://doi.org/10.1177/0885328203017003557
]Search in Google Scholar
[
7. A. Deshmukh, P. Nakhat and P. Yeole, Formulation and in-vitro evaluation of self microemulsifying drug delivery system (SMEDDS) of furosemide, Der Pharmacia Lettre 2 (2010) 94–106.
]Search in Google Scholar
[
8. S. Sambaraj, D. Ammula and V. Nagabandi, Furosemide loaded silica-lipid hybrid microparticles: Formulation development, in vitro and ex vivo evaluation, Adv. Pharm. Bull. 5 (2015) 403–409.
]Search in Google Scholar
[
9. N. J. Clear, A. Milton, M. Humphrey, B. T. Henry, M. Wulff, D. J. Nichols, R. J. Anziano and I. Wilding, Evaluation of the Intelisite capsule to deliver theophylline and frusemide tablets to the small intestine and colon, Eur. J. Pharm. Sci. 13 (2001) 375–384.
]Search in Google Scholar
[
10. L. Å. Brodin, Τ. Jogestrand, F. Larsen, G. Walldius and B. Tedner, Effects of furosemide and slow-release furosemide on thoracic fluid volumes, Clin. Cardiol. 9 (1986) 561–564; https://doi.org/10.1002/clc.4960091107
]Search in Google Scholar
[
11. Μ. Efentakis, A. Koutlis and M. Vlachou, Development and evaluation of oral multiple-unit and single-unit hydrophilic controlled-release systems, AAPS Pharm. Sci. Tech. 1 (2000) 62–70; https://doi.org/10.1208/pt010434
]Search in Google Scholar
[
12. D. Jain, S. Verma, S. B. Shukla, A. K. Jain, P. Jain, P. Yadav, Formulation and evaluation of gastro-retentive tablets of Furosemide (Evaluation based on drug release kinetics and factorial designs), J. Chem. Pharm. Res. 2 (2010) 935–978.
]Search in Google Scholar
[
13. T. Terao, K. Matsuda and H. Shouji, Improvement in site-specifc intestinal absorption of furosemide by Eudragit L100-55, JPP 53 (2001) 433–440.
]Search in Google Scholar
[
14. J. M. Aceves, R. Cruz and E. Hernandez, Preparation and characterization of furosemide-eudragit controlled release systems, Int. J. Pharm. 195 (2000) 45–53; https://doi.org/10.1016/S0378-5173(99)00303-8
]Search in Google Scholar
[
15. M. Vlachou, A. Siamidi, S. Konstantinidou and Y. Dotsikas, Optimization of controlled release matrix formulation of melatonin via experimental design, JPDDR 5 (2016) 1–5; https://doi.org/10.4172/2325-9604.1000159
]Search in Google Scholar
[
16. M. Vlachou, A. Siamidi and M. Efentakis, Investigation of a novel “tablets in capsule” theophyl-line formulation system for modified release, Pharm. Pharmacol. Int. J. 5 (2017) 51–56; https://doi.org/10.15406/ppij.2017.05.00115
]Search in Google Scholar
[
17. M. Vlachou, A. Siamidi, E. Diamantidi, A. Iliopoulou, I. Papanastasiou, V. Ioannidou, V. Kourbeli, A.-S. Foscolos, A. Vocat, S. T. Colec, V. Karalis, T. Kellici and T. Mavromoustakos, In vitro controlled release from solid pharmaceutical formulations of two new adamantane aminoethers with antitubercular activity (I) Drug Res. 67 (2017) 447–450; https://doi.org/10.1055/s-0042-121491
]Search in Google Scholar
[
18. M. Vlachou, A. Siamidi, D. Spaneas, D. Lentzos, P. Ladia, K. Anastasiou, I. Papanastasiou, A-S. Foscolos, M-O. Georgiadis, V. Karalis, T. Kellici and T. Mavromoustakos, In vitro controlled release of two new tuberculocidal adamantane aminoethers from solid pharmaceutical formulations (II) Drug Res. 67 (2017) 653–660; https://doi.org/10.1055/s-0043-114012
]Search in Google Scholar
[
19. M. Vlachou, M. Papamichael, A. Siamidi, I. Fragouli, P. A. Afroudakis, R. Kompogennitaki and Y. Dotsikas, Comparative in vitro controlled release studies on the chronobiotic hormone melatonin from cyclodextrins-containing matrices and cyclodextrin: Melatonin complexes, Int. J. Mol. Sci. 18 (2017) 1641; https://doi.org/10.3390/ijms18081641
]Search in Google Scholar
[
20. M. Vlachou, K.Tragou, A. Siamidi, S. Kikionis, A. L. Chatzianagnostou, A. Mitsopoulos, E. Ioannou, V. Roussis and A. Tsotinis, Modified in vitro release of the chronobiotic hormone melatonin from matrix tablets based on the marine sulfated polysaccharide ulvan, J. Drug Deliv. Sci. Technol. 44 (2018) 41–48; https://doi.org/10.1016/j.jddst.2017.11.019
]Search in Google Scholar
[
21. M. Vlachou, S. Kikionis, A. Siamidi, K. Tragou, S. Kapoti, E. Ioannou, V. Roussis and A. Tsotinis. Fabrication and characterization of electrospun nanofibers for the modified release of the chronobiotic hormone melatonin, Curr. Drug Deliv. 16 (2019) 79–85; https://doi.org/10.2174/1567201815666180914095701
]Search in Google Scholar
[
22. S. Bose and R. H. Bogner, Solventless pharmaceutical coating processes: A review, Pharm. Dev. Techn. 12 (2007) 115–131; https://doi.org/10.1080/10837450701212479
]Search in Google Scholar
[
23. M. Efentakis and M. Vlachou, Evaluation of high molecular weight poly(oxyethylene) (polyox) polymer: Studies of flow properties and release rates of furosemide and captopril from controlled-release hard gelatin capsules, Pharm. Dev. Technol. 5 (2000) 339–346; https://doi.org/10.1081/PDT-100100549
]Search in Google Scholar
[
24. O. Mansour, G. Ismail, M. Isbera and M. Almouhammad, Assessment of physicochemical properties of furosemide (40 mg) tablets marketed in Syria, JCPS 9 (2016) 2879–2881.
]Search in Google Scholar
[
25. https://www.jchps.com/issues/Volume%209_Issue%204/jchps%209(4)%20223%200570616%202879-2881.pdf
]Search in Google Scholar
[
26. K.A. Khan, The concept of dissolution efficiency, J. Pharm. Pharmacol. 27 (1975) 48–49; https://doi.org/10.1111/j.2042-7158.1975.tb09378.x
]Search in Google Scholar
[
27. W. R. Korsmeyer, R. Gurny, E. Doelker, P. Buri and N. A. Peppas, Mechanisms of solute release from porous hydrophilic polymers, Int. J. Pharmaceut. 15 (1983) 25–35; https://doi.org/10.1016/0378-5173(83)90064-9
]Search in Google Scholar
[
28. N. A. Peppas and J. J. Sahlin, A simple equation for the description of solute release coupling of diffusion and relaxation, Int. J. Pharmaceut. 57 (1989) 169–172; https://doi.org/10.1016/0378-5173(89)90306-2
]Search in Google Scholar
[
29. G. Singhvi and M. Singh, Review: in-vitro drug release characterization models, Int. J. Pharm. Sci. Res. 2 (2011) 77–84.
]Search in Google Scholar
[
30. S. Ummadi, B. Shravani, N. G. Raghavendra Rao, S. Reddy, B. Sanjeev, Overview on controlled release dosage form, Int. J. Pharm. Sci. 3 (2013) 258–269; http://ijps.aizeonpublishers.net/content/2013/4/ijps258-269.pdf
]Search in Google Scholar
[
31. S. Bose and R. H. Bogner, Solventless pharmaceutical coating processes: A review, Pharm. Dev. Technol. 12 (2007) 115–131 https://doi.org/10.1080/10837450701212479
]Search in Google Scholar
[
32. X. Gong, C.C. Sun, A new tablet brittleness index, Eur. J. Pharm. Biopharm. 93 (2015) 260–266; https://doi.org/10.1016/j.ejpb.2015.04.007
]Search in Google Scholar
[
33. M. Han, Q. Yu, X. Liu, F. Hu and H. Yuan, Preparation and characterization of a novel aqueous dispersion for enteric coating of pantoprazole sodium pellets, Acta Pharm. 68 (2018) 441–455; https://doi.org/https://doi.org/10.2478/acph-2018-0035
]Search in Google Scholar
[
34. J. Akbuga, Preparation and evaluation of controlled release furosemide microspheres by spherical crystallization, Int. J. Pharm. 53 (1999) 99–105; https://doi.org/10.1016/0378-5173(89)90233-0
]Search in Google Scholar
[
35. B. N.Tukaram, I. V. Rajagopalan and P. S. Ikumar Shartchandra, The effects of lactose, microcrystalline cellulose and dicalcium phosphate on swelling and erosion of compressed hpmc matrix tablets: texture analyzer, Iranian J. Pharm. Res. 9 (2010) 349–358.
]Search in Google Scholar
[
36. V. Iannuccelli, G. Coppi, E. Leo, F. Fontana and M. T. Bernabei, PVP solid dispersions for the controlled release of furosemide from a floating multiple-unit system, Drug Dev. Ind. Pharm. 26 (2000) 595–603.
]Search in Google Scholar
[
37. A. Cismesia, G. R. Nicholls and N. C. Polfer, Amine vs. carboxylic acid protonation in ortho-, meta-, and para aminobenzoic acid: An IRMPD spectroscopy study, J. Mol. Spectrosc. 332 (2017) 79–85; https://doi.org/10.1016/j.jms.2016.10.020
]Search in Google Scholar
[
38. A. Apicella, B. Cappello, M. A. Del Nobile, M. I. La Rotonda, G. Mensitieria and L. Nicolais, Poly(ethylene oxide) (PEO) and different molecular weight PEO blends monolithic devices for drug release, Biomaterials 14 (1993) 83–90; https://doi.org/10.1016/0142-9612(93)90215-N
]Search in Google Scholar
